![Alberto Sanchez Fueyo](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Alberto Sanchez Fueyo
Director/Miembro de la Junta en Quell Therapeutics Ltd. .
Cargos activos de Alberto Sanchez Fueyo
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Quell Therapeutics Ltd.
![]() Quell Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Quell Therapeutics Ltd. is a London-based biotechnology company, which develops immune cell therapies to target transplant rejection, autoimmune and inflammatory diseases. It develops engineered T regulatory cell therapies for a variety of non-cancer targets. The company was founded on March 19, 2019 and is headquartered in London, the United Kingdom. | Director/Miembro de la Junta | 29/03/2019 | - |
Historial de carrera de Alberto Sanchez Fueyo
Estadísticas
Internacional
Reino Unido | 2 |
Operativa
Director/Board Member | 1 |
Sectorial
Health Technology | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 1 |
---|---|
Quell Therapeutics Ltd.
![]() Quell Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Quell Therapeutics Ltd. is a London-based biotechnology company, which develops immune cell therapies to target transplant rejection, autoimmune and inflammatory diseases. It develops engineered T regulatory cell therapies for a variety of non-cancer targets. The company was founded on March 19, 2019 and is headquartered in London, the United Kingdom. | Health Technology |